ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE

CHEBI:CHEBI_756769

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
259081
pharm_class
Decreased Platelet Aggregation [PE]
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
route
ORAL
marketing_category
ANDA
dosage_form
CAPSULE
active_ingredient_strength
200 mg/1
nui
N0000008832
pharm_class_epc
Platelet Aggregation Inhibitor [EPC]
pharm_class_moa
Cyclooxygenase Inhibitors [MoA]
pharm_class_cs
Anti-Inflammatory Agents, Non-Steroidal [CS]
pharm_class_pe
Decreased Platelet Aggregation [PE]
active_ingredient_name
DIPYRIDAMOLE
unii
64ALC7F90C
marketing_start_date
20190524
package_marketing_start_date
20190524
labeler_name
Glenmark Pharmaceuticals Inc., USA
manufacturer_name
Glenmark Pharmaceuticals Inc., USA
generic_name
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
brand_name
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
brand_name_base
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
product_ndc
68462-405
application_number
ANDA210318
spl_id
1d9d072a-e721-450d-b80d-12dd480e6f5d
package_ndc
68462-405-60
package_description
60 CAPSULE in 1 BOTTLE (68462-405-60)
spl_set_id
467d6ce3-bc05-4aa1-87cc-3214fd628d39
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class